Electromed, Inc. has announced its financial results for the first fiscal quarter of 2027, showcasing a robust performance that highlights the company's continued growth trajectory. The results, released on November 10, 2026, indicate that Electromed has achieved its 16th consecutive quarter of year-over-year revenue and operating income growth, a significant milestone for the company.
For the quarter ending September 30, 2026, Electromed reported net revenues of $18.7 million, a 10.6% increase compared to $16.9 million in the same quarter of the previous fiscal year. The company also saw its operating income rise to $3.5 million, reflecting a 30.7% increase from the prior year's first quarter. This strong performance is attributed to a 17.6% growth in the core homecare market, which has been a focal point for the company.
Electromed, Inc., based in New Prague, Minnesota, specializes in the manufacturing of electromechanical and electrotherapeutic apparatus, specifically focusing on innovative airway clearance technologies. The company trades on the NYSE under the ticker symbol ELMD and is classified under the Standard Industrial Classification (SIC) code 3845.
The recent filing reveals that Electromed's net income for the quarter was $2.8 million, or $0.32 per diluted share, marking a 29.3% increase from $2.1 million, or $0.25 per diluted share, in the same quarter last year. The company has also returned $4.3 million to shareholders through share repurchases while maintaining a debt-free status, which underscores its strong financial health.
In a statement, Jim Cunniff, President and CEO of Electromed, expressed confidence in the company’s direction: “We delivered our 16th consecutive quarter of year-over-year revenue and operating income growth, with double-digit revenue growth, a 30.7% increase in operating income and an 80.0% gross margin—demonstrating the strength of our direct-to-patient model and operating leverage.”
The filing also included an updated investor presentation intended for use in meetings with investors and analysts, indicating Electromed's proactive approach in communicating its growth story and strategic direction. The updated presentation is available as Exhibit 99.2 in the filing.
Looking ahead, Electromed is well-positioned to expand its reach in the market, particularly in the homecare segment, where it has seen substantial growth. The company aims to leverage its strong balance sheet and effective sales strategies to continue delivering value to its customers and shareholders.
As Electromed continues to navigate the competitive landscape of the electromechanical and electrotherapeutic apparatus industry, its latest results may set a positive tone for investor sentiment and influence market dynamics in the healthcare technology sector.
Read Next
Madison Technologies reports Q3 results with net loss
Cyberloq Technologies Releases Q3 Results Amid Challenges
Specificity, Inc. Reports Q3 2026 Financial Results
SUNation Energy reports Q3 2026 financial results
Vystar Corp reports on Q3 performance in latest filing
Alpex Acquisition Corp Reports Quarterly Results










